The HPTN 083 study team and the Community Relation Coordinator visited the Caremat Health Center and Mplus foundation on October 8, 2020 and October 22, 2020 respectively.
​
The final results of HPTN 083 study on the long acting antiretroviral injection cabotegravir as a new HIV prevention strategy have been discussed with these community-based organizations who have been actively working on HIV prevention for the specific population; MSMs/TGs and adolescents.